Trials / Completed
CompletedNCT05175339
Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19)
Long-term Impact in Intensive Care Survivors of Coronavirus Disease-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The Investigator seeks to evaluate the long term neurological and pulmonary sequelae of COVID-19.
Detailed description
Recent data suggests that survivors of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or (COVID-19) report adverse health status, including neurological and cognitive deficits and impaired pulmonary function, even months after discharge. Adult COVID-19 survivors after ICU stay, who are noted to have increased mortality and organ failure, are at higher risk of long-term disabilities and impaired quality of life. This study is one branch of a multi-site study coordinated by Gilead Sciences, in which participants who were critically ill with COVID-19 will be followed at three and nine months after discharge to test pulmonary function, cognitive function, and quality of life.
Conditions
Timeline
- Start date
- 2021-09-29
- Primary completion
- 2023-11-13
- Completion
- 2023-11-13
- First posted
- 2022-01-03
- Last updated
- 2023-11-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05175339. Inclusion in this directory is not an endorsement.